Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.12 GBX | +0.71% | -4.89% | -75.54% |
Apr. 25 | Norcros sells Johnson Tiles UK; Trifast trading well | AN |
Apr. 25 | Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024 |
Sales 2023 | 832K 1.04M | Sales 2024 * | 533K 668K | Capitalization | 16.2M 20.29M |
---|---|---|---|---|---|
Net income 2023 | -5M -6.26M | Net income 2024 * | -5M -6.26M | EV / Sales 2023 | 72.5 x |
Net cash position 2023 | 6.38M 7.99M | Net cash position 2024 * | 2.25M 2.82M | EV / Sales 2024 * | 26.2 x |
P/E ratio 2023 |
-11.3
x | P/E ratio 2024 * |
-2.79
x | Employees | 24 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 75.35% |
Latest transcript on Destiny Pharma plc
1 day | +0.71% | ||
1 week | -4.89% | ||
Current month | -3.55% | ||
1 month | -2.17% | ||
3 months | -62.78% | ||
6 months | -76.55% | ||
Current year | -75.54% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 23-08-31 | |
William Love
FOU | Founder | 62 | 96-03-03 |
Shaun Claydon
DFI | Director of Finance/CFO | 56 | 18-10-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Rudd
CHM | Chairman | 76 | 11-08-31 |
William Love
FOU | Founder | 62 | 96-03-03 |
Nigel Brooksby
BRD | Director/Board Member | - | 22-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 17.12 | +0.71% | 7 273 |
24-05-10 | 17 | -2.86% | 151,287 |
24-05-09 | 17.5 | +2.94% | 7,648 |
24-05-08 | 17 | -5.56% | 157,421 |
24-05-07 | 18 | -1.37% | 225,759 |
Delayed Quote London S.E., May 13, 2024 at 04:28 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-75.54% | 20.28M | |
+3.91% | 109B | |
+10.87% | 105B | |
-0.49% | 22.25B | |
-13.14% | 22.09B | |
-7.82% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- DEST Stock